Postmarketing surveillance of ketotifen (Zaditen) for asthma prophylaxis found it effective in 70% of patients. This study confirmed known efficacy and safety, similar to clinical trials, with no unexpected side effects.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: